Results 1 to 10 of about 37,807 (264)

Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background In addition to primary neurodegenerative processes, vascular disorders, such as stroke, can lead to parkinsonism. However, some cardiovascular risk factors, such as smoking and elevated cholesterol levels, are associated with reduced risk of ...
Jens Sundbøll, Szimonetta Komjáthiné Szépligeti, Péter Szentkúti, Kasper Adelborg, Erzsébet Horváth‐Puhó, Lars Pedersen, Victor W. Henderson, Henrik Toft Sørensen   +7 more
doaj   +4 more sources

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism

Journal of Multidisciplinary Healthcare, 2018
Orjan Skogar,1,2 Mats Nilsson1,3 1FUTURUM, Academy for Health and Care, Region Jönköping County, Jönköping, Sweden; 2Institution of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden; 3Department of ...
Skogar O, Nilsson M
doaj   +4 more sources

Self-management Interventions for People With Parkinson Disease: Scoping Review

Journal of Medical Internet Research, 2022
BackgroundParkinson disease can impose substantial distress and costs on patients, their families and caregivers, and health care systems.
Madison Milne-Ives, Camille Carroll, Edward Meinert   +2 more
doaj   +1 more source

A Video Self-Modeling Intervention Using Virtual Reality Plus Physical Practice for Freezing of Gait in Parkinson Disease: Feasibility and Acceptability Study

JMIR Formative Research, 2021
BackgroundDespite optimal medical and surgical intervention, freezing of gait commonly occurs in people with Parkinson disease.
Lina Goh, Natalie E Allen, Naseem Ahmadpour, Kaylena A Ehgoetz Martens, Jooeun Song, Lindy Clemson, Simon J G Lewis, Hamish G MacDougall, Colleen G Canning   +8 more
doaj   +1 more source

Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial. [PDF]

PLoS ONE, 2016
In the present study, we examined the potential symptomatic and/or disease-modifying effects of monthly bee venom injections compared to placebo in moderatly affected Parkinson disease patients.
Andreas Hartmann, Julia Müllner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck, Marie-Odile Habert, Aurélie Kas, Marie-Laure Tanguy, Merry Mazmanian, Hervé Oya, Nissen Abuaf, Hafida Gaouar, Sabrina Salhi, Fanny Charbonnier-Beaupel, Marie-Hélène Fievet, Damien Galanaud, Sophie Arguillere, Emmanuel Roze, Bertrand Degos, David Grabli, Lucette Lacomblez, Cécile Hubsch, Marie Vidailhet, Anne-Marie Bonnet, Jean-Christophe Corvol, Michael Schüpbach   +25 more
doaj   +1 more source

The Impact of a Digital Artificial Intelligence System on the Monitoring and Self-management of Nonmotor Symptoms in People With Parkinson Disease: Proposal for a Phase 1 Implementation Study

JMIR Research Protocols, 2022
BackgroundNonmotor symptoms of Parkinson disease are a major factor of disease burden but are often underreported in clinical appointments.
Edward Meinert, Madison Milne-Ives, K Ray Chaudhuri, Tracey Harding, John Whipps, Susan Whipps, Camille Carroll   +6 more
doaj   +1 more source

Parkinson's Syndrome Secondary to Congenital Absence of the Left Internal Carotid Artery: a Case Report and Review of the Literature [PDF]

Zhongguo quanke yixue, 2023
Congenital absence of the internal carotid artery (ICA) is a rare congenital developmental anomaly, which is often associated with carotid canal atresia and structural abnormalities of the ICA. It may be asymptomatic, or shows noticeable symptoms such as
SUN Xiaoling, LI Zhijun
doaj   +1 more source

Refractory Seizures Secondary to Vitamin B6 Deficiency in Parkinson Disease: The Role of Carbidopa-Levodopa

Case Reports in Neurology, 2022
Carbidopa-levodopa has been used for more than 50 years in the treatment of Parkinson disease (PD) and other movement disorders. Pyridoxal 5′-phosphate (PLP), an active form of vitamin B6 (pyridoxine), is involved in the decarboxylation of levodopa to ...
Adina Wise, Hernan Nicolas Lemus, Madeline Fields, Matthew Swan, Susan Bressman   +4 more
doaj   +1 more source

Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)

BMC Neurology, 2021
Background Culminating evidence shows that current care does not optimally meet the needs of persons with parkinsonism, their carers and healthcare professionals.
Jan H. L. Ypinga, Angelika D. Van Halteren, Emily J. Henderson, Bastiaan R. Bloem, Agnes J. Smink, Emma Tenison, Marten Munneke, Yoav Ben-Shlomo, Sirwan K. L. Darweesh   +8 more
doaj   +1 more source

Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease [PDF]

International Journal of Molecular Sciences, 2021
Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dysregulated pathways in PD.
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, Esra Küpeli Akkol, Mohammad Hosein Farzaei, Eduardo Sobarzo-Sánchez   +5 more
openaire   +3 more sources